Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma.
M L Sánchez de MolinaC Díaz Del ArcoP VorwaldD García-OlmoL EstradaMaría Jesús Fernández AceñeroPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)
Our study indicates that undifferentiated tumors respond worse to therapy. Furthermore, studies are necessary to define lack of response, to help avoid neoadjuvant therapy in unfavorable cases.
Keyphrases